111 Inc (YI)

4.120
-0.240(-5.50%)
After Hours
4.100
-0.050(-1.205%)
- Real-time Data
  • Volume:
    169,268
  • Bid/Ask:
    4.080/4.110
  • Day's Range:
    3.960 - 4.190

YI Overview

Prev. Close
4.36
Day's Range
3.96-4.19
Revenue
1.82B
Open
4.17
52 wk Range
3.74-45.2
EPS
-1.3
Volume
169,268
Market Cap
341.44M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
264,813
P/E Ratio
-
Beta
-
1-Year Change
-38.96%
Shares Outstanding
82,873,357
Next Earnings Date
Mar 16, 2022
What is your sentiment on 111 Inc?
or
Market is currently closed. Voting is open during market hours.

111 Inc Company Profile

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; Jianming Pharmaceutical Group; and Chugai Pharma China Co., Ltd. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryBuyNeutralStrong SellStrong SellStrong Sell
  • What’s going on here?
    0
    • Reversal confirmed. We move on. This is a small cap company. It gave what it was meant to give.
      3
      • will this go back up tomorrow morning?
        0
        • No, target was met too soon. I believe 26 will be very strong resistance. We will range between 5-26 for the next months
          0
      • down 30%, will this go back up tomorrow morning?
        0
        • Long bullish ^
          0
          • now it's crash time.
            0
            • don't buy above 18.5
              0
            • Asheell Remeealthough from this movement today I believe it will settle below 10
              0
          • No roof for this stock. Keep buying on dips
            1
            • where is this going?
              1
              • To the moon
                1
            • Above 50 soon
              0
              • why
                1
            • I am here - this looks weird jumps from 9 to 11 and back and forth... TOXIC  baiting people..scam
              1
              • Somebody here?
                0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.